LeadIQ logo
Learn more at LeadIQ.com

Insights

Strategic Partnerships Arcutis Biotherapeutics, Inc. has partnered with Kowa Company Ltd., demonstrating a commitment to expanding its market reach and leveraging synergies to drive sales growth through co-promotion agreements.

Product Launch The recent launch of ZORYVE(R) cream for treating Atopic Dermatitis provides a new product offering that opens avenues for capturing market share and driving sales through addressing unmet medical needs.

Experienced Management With a management team boasting a successful track record in developing over 50 FDA-approved products and expertise in medical dermatology, Arcutis is well-positioned to drive sales by leveraging industry knowledge and experience.

Recent Investments Acadian and Capstone Investment Advisors have made significant investments in Arcutis Biotherapeutics, Inc., signaling investor confidence which can be leveraged to boost sales initiatives and drive business expansion.

Key Executive Appointments The appointments of David Topper as Chief Financial Officer and Todd Tucker as Chief Human Resources Officer showcase organizational strengthening, providing a solid foundation to support sales growth and business development efforts.

Similar companies to Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT)

Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT) Tech Stack

Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT) uses 8 technology products and services including SiteCatalyst, Fastly, SAP, and more. Explore Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT)'s tech stack below.

  • SiteCatalyst
    Analytics
  • Fastly
    Content Delivery Network
  • SAP
    Customer Relationship Management
  • MariaDB
    Database
  • Microsoft PowerPoint
    Editors
  • Sophos
    Email Security
  • Twitter Emoji (Twemoji)
    Font Scripts
  • RSS
    Miscellaneous

Media & News

Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT)'s Email Address Formats

Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT) uses at least 1 format(s):
Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT) Email FormatsExamplePercentage
FLast@arcutis.comJDoe@arcutis.com
94%
Last@arcutis.comDoe@arcutis.com
4%
First-Last@arcutis.comJohn-Doe@arcutis.com
1%
FirstLast@arcutis.comJohnDoe@arcutis.com
1%

Frequently Asked Questions

Where is Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT)'s headquarters located?

Minus sign iconPlus sign icon
Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT)'s main headquarters is located at 2945 Townsgate Rd Westlake Village, California 91361 US. The company has employees across 2 continents, including North AmericaEurope.

What is Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT)'s official website and social media links?

Minus sign iconPlus sign icon
Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT)'s official website is arcutis.com and has social profiles on LinkedIn.

How much revenue does Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT) generate?

Minus sign iconPlus sign icon
As of September 2024, Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT)'s annual revenue reached $15M.

What is Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT)'s SIC code NAICS code?

Minus sign iconPlus sign icon
Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT)'s SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT) have currently?

Minus sign iconPlus sign icon
As of September 2024, Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT) has approximately 343 employees across 2 continents, including North AmericaEurope. Key team members include Chief Commercial Officer: T. E.Chief Medical Officer: P. B.Chief Compliance & Privacy Officer: C. B.. Explore Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT)'s employee directory with LeadIQ.

What industry does Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT) belong to?

Minus sign iconPlus sign icon
Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT) operates in the Biotechnology Research industry.

What technology does Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT) use?

Minus sign iconPlus sign icon
Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT)'s tech stack includes SiteCatalystFastlySAPMariaDBMicrosoft PowerPointSophosTwitter Emoji (Twemoji)RSS.

What is Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT)'s email format?

Minus sign iconPlus sign icon
Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT)'s email format typically follows the pattern of . Find more Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT) email formats with LeadIQ.

How much funding has Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT) raised to date?

Minus sign iconPlus sign icon
As of September 2024, Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT) has raised $150M in funding. The last funding round occurred on Feb 28, 2024 for $150M.

When was Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT) founded?

Minus sign iconPlus sign icon
Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT) was founded in 2016.
Arcutis Biotherapeutics, Inc.  (Nasdaq: ARQT)

Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT)

Biotechnology ResearchCalifornia, United States201-500 Employees

Arcutis (Nasdaq: ARQT) was founded in 2016 to address significant unmet needs in medical dermatology. The company is an early commercial stage biopharmaceutical company focused on developing and commercializing best-in-class products.

Our strategy is to exploit recent innovations in inflammation and immunology to bring the best molecules to bear against validated physiologic targets known to treat dermatological diseases and disorders. 

Our management team has extensive expertise in the development and commercialization of medical dermatology products, having held key leadership roles at a number of leading dermatology companies and, collectively, has successfully developed more than 50 FDA-approved products. We believe that by leveraging our team’s unique experience and demonstrated expertise to identify, develop and commercialize best-in-class molecules against validated targets, we will be able to develop differentiated products in less time, at lower cost, and at substantially lower risk than other approaches.

Arcutis'​ combination of vision, unmet medical need, experienced management and strategic approach has attracted support from leading investors in the life sciences sector.

Section iconCompany Overview

Headquarters
2945 Townsgate Rd Westlake Village, California 91361 US
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2016
Employees
201-500

Section iconFunding & Financials

  • $150M

    Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT) has raised a total of $150M of funding over 8 rounds. Their latest funding round was raised on Feb 28, 2024 in the amount of $150M.

  • $10M$50M

    Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT)'s revenue is in the range of $10M$50M

Section iconFunding & Financials

  • $150M

    Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT) has raised a total of $150M of funding over 8 rounds. Their latest funding round was raised on Feb 28, 2024 in the amount of $150M.

  • $10M$50M

    Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT)'s revenue is in the range of $10M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.